The kin17 Protein in Murine Melanoma Cells

Anelise C Ramos1, Vanessa P Gaspar2, Sabrina M G Kelmer3

  • 1Departamento de Biotecnologia, Genética e Biologia Celular, Universidade Estadual de Maringá, 87020-900 Maringá, Paraná, Brazil. anelise.andre@gmail.com.

Insights

The protein kin17, involved in DNA replication and repair, was detected in melanoma cells. Its elevated expression in low-metastatic melanoma cells suggests kin17 may serve as a melanoma marker.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The protein kin17 is recognized for its roles in DNA replication initiation, DNA recombination, and DNA repair.
  • Previous research has explored kin17 as a potential molecular marker for breast cancer.
  • The metastatic potential of melanoma cells is a critical factor in disease progression and patient outcomes.

Purpose of the Study:

  • To detect and localize the kin17 protein within the murine melanoma cell line B16F10-Nex2.
  • To investigate kin17 expression in subclones with varying metastatic potentials (B16-8HR and B16-10CR).
  • To evaluate the potential of kin17 as a molecular marker for melanoma progression.

Main Methods:

  • Analysis of nuclear and chromatin-associated protein fractions from melanoma cell lines.
  • Detection and quantification of kin17 protein levels in different cellular fractions.
  • Comparison of kin17 expression across melanoma subclones with distinct metastatic capabilities.

Main Results:

  • Kin17 protein was detected in both nuclear and chromatin-associated fractions of all tested melanoma cell lines.
  • An elevated concentration of kin17 was observed in the chromatin-associated fraction of the melanoma subclone exhibiting low metastatic potential (B16-8HR).
  • Differential expression patterns of kin17 were noted between melanoma subclones with varying metastatic potentials.

Conclusions:

  • The study successfully detected and localized kin17 in murine melanoma cells.
  • The findings suggest that kin17 expression levels, particularly in chromatin-associated fractions, may correlate with melanoma metastatic potential.
  • Kin17 is proposed as a potential novel molecular marker for assessing melanoma progression and aggressiveness.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K